New Delhi: Digital health platform Tata 1mg is in advanced talks to raise around USD 200 million, with leading global investors including Novo Holdings, Canada Pension Plan Investment Board (CPPIB), Permira, and ChrysCapital showing strong interest.

According to a recent media report in the Economic Times, the discussions, however, face a valuation hurdle. While Tata 1mg was valued at $1.25 billion post-money in its 2022 round, potential investors are reportedly pushing for a revised valuation in the $750–800 million range. In addition, some are demanding board seats and additional rights, conditions the company is unwilling to accept.

If the deadlock continues, Tata Sons may step in with about $75 million in a down round, or the company may opt for a smaller fundraising exercise. Sourc

See Full Page